Related content

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia

By Thompson Andrew B.   Ross Douglas A.   Berard Paul   Figueroa-Bodine Jaszmin   Livada Nancy   Richer Sara L.  

Allergy & Rhinology, Vol. 5, Iss. 2, 2014-07 ,pp. : 91-95

OceanSide Publications, Inc

Access to resources Recommend Favorite

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks

By Craig Timothy J.   Bewtra Againdra K.   Hurewitz David   Levy Robyn   Janss Gerti   Jacobson Kraig W.   Packer Flint   Bernstein Jonathan A.   Rojavin Mikhail A.   Machnig Thomas   Keinecke Heinz-Otto   Wasserman Richard L.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 4, 2012-07 ,pp. : 354-361

OceanSide Publications, Inc

Access to resources Recommend Favorite

Significance of phosphoinositide 3-kinase pathway on ischemic preconditioning followed by ischemia reperfusion in mice liver

By Izuishi K.   Fujiwara M.   Hossain M.A.   Usuki H.   Maeta H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 132-133

Elsevier

Access to resources Recommend Favorite

Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85α

By Donahue Amber C.   Hess Kristen L.   Ng Kwan L.   Fruman David A.  

International Immunology, Vol. 16, Iss. 12, 2004-12 ,pp. : 1789-1798

Oxford University Press

Access to resources Recommend Favorite

A postal survey of hereditary hemorrhagic telangectasia in the northeast of England

By Ramakrishnan Yujay   Iqbal Isma Z.   Puvanendran Mark   ElBadawey Mohamed Reda   Carrie Sean  

Allergy & Rhinology, Vol. 6, Iss. 1, 2015-01 ,pp. : e20-e27

OceanSide Publications, Inc

Access to resources Recommend Favorite